Institutional Review of Ovoid Surface Dose and Physician Variability In HDR Brachytherapy: A Step Toward Vaginal Dose De-Escalation
The 2018 EMBRACE II study emphasizes minimizing vaginal mucosal dose during locally advanced cervical cancer brachytherapy. While traditional organs at risk include bladder, rectum, and sigmoid, vaginal mucosa dose has gained attention due to late toxicities...
Poster Program · Therapy Physics